Gali Bar

1.1k total citations
10 papers, 817 citations indexed

About

Gali Bar is a scholar working on Psychiatry and Mental health, Clinical Psychology and Biological Psychiatry. According to data from OpenAlex, Gali Bar has authored 10 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Clinical Psychology and 3 papers in Biological Psychiatry. Recurrent topics in Gali Bar's work include Schizophrenia research and treatment (4 papers), Tryptophan and brain disorders (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Gali Bar is often cited by papers focused on Schizophrenia research and treatment (4 papers), Tryptophan and brain disorders (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Gali Bar collaborates with scholars based in Israel and United States. Gali Bar's co-authors include Uriel Heresco‐Levy, Marina Ermilov, Daniel C. Javitt, Ágnes Vass, Richard P. Ebstein, Pesach Lichtenberg, Daniel C. Javitt, Yehuda Baruch, Jack Asherov and Amihai Rigbi and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Schizophrenia Research.

In The Last Decade

Gali Bar

10 papers receiving 786 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gali Bar Israel	7	367	277	266	221	210	10	817
Ágnes Vass Israel	6	246 0.7×	218 0.8×	190 0.7×	154 0.7×	145 0.7×	17	566
Alessandra Solida Switzerland	11	180 0.5×	107 0.4×	281 1.1×	128 0.6×	277 1.3×	32	854
George Garibaldi Switzerland	12	249 0.7×	85 0.3×	195 0.7×	221 1.0×	559 2.7×	21	1000
Dragana Bugarski‐Kirola United States	12	242 0.7×	91 0.3×	177 0.7×	166 0.8×	550 2.6×	30	878
Hitoshi Maeshima Japan	20	116 0.3×	125 0.5×	262 1.0×	148 0.7×	240 1.1×	35	806
Don Goff United States	10	471 1.3×	93 0.3×	161 0.6×	300 1.4×	596 2.8×	13	1.3k
John R. Saksa United States	14	265 0.7×	141 0.5×	147 0.6×	119 0.5×	502 2.4×	17	1.2k
Н. Г. Незнанов Russia	14	683 1.9×	50 0.2×	233 0.9×	502 2.3×	353 1.7×	123	1.5k
А С Аведисова Russia	9	597 1.6×	36 0.1×	185 0.7×	421 1.9×	274 1.3×	40	1.1k
M.D.C. Simpson United Kingdom	15	755 2.1×	58 0.2×	164 0.6×	432 2.0×	309 1.5×	34	1.1k

Countries citing papers authored by Gali Bar

Since Specialization

Citations

This map shows the geographic impact of Gali Bar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gali Bar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gali Bar more than expected).

Fields of papers citing papers by Gali Bar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gali Bar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gali Bar. The network helps show where Gali Bar may publish in the future.

Co-authorship network of co-authors of Gali Bar

This figure shows the co-authorship network connecting the top 25 collaborators of Gali Bar. A scholar is included among the top collaborators of Gali Bar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gali Bar. Gali Bar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Shelef, Assaf, Uri Berger, Yehuda Baruch, et al.. (2017). Deliberate Self-Harm in Older Adults: A General Hospital Emergency Department Survey.. PubMed. 19(3). 160–163. 6 indexed citations

Yovell, Yoram, Gali Bar, Yehuda Baruch, et al.. (2015). Ultra-Low-Dose Buprenorphine as a Time-Limited Treatment for Severe Suicidal Ideation: A Randomized Controlled Trial. American Journal of Psychiatry. 173(5). 491–498. 173 indexed citations

Bar, Gali, et al.. (2012). Impact of Co-Morbid Mental Illness on the Diagnosis and Management of Patients Hospitalized for Medical Conditions in a General Hospital. The International Journal of Psychiatry in Medicine. 43(4). 339–348. 34 indexed citations

Heresco‐Levy, Uriel, Gali Bar, Raz Levin, et al.. (2007). High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients. Schizophrenia Research. 91(1-3). 14–21. 30 indexed citations

Lichtenberg, Pesach, et al.. (2007). Reduced prepulse inhibition is associated with increased hypnotizability. The International Journal of Neuropsychopharmacology. 11(4). 541–5. 14 indexed citations

Heresco‐Levy, Uriel, Daniel C. Javitt, Richard P. Ebstein, et al.. (2005). D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia. Biological Psychiatry. 57(6). 577–585. 303 indexed citations

Shefler, Gaby, et al.. (2005). Characteristics of schizophrenia residents and staff rejection in community mental health hostels.. PubMed. 42(1). 23–32. 4 indexed citations

Heresco‐Levy, Uriel, et al.. (2004). High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biological Psychiatry. 55(2). 165–171. 169 indexed citations

Kremer, I, et al.. (2004). Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia. Biological Psychiatry. 56(6). 441–446. 80 indexed citations

10.

Ermilov, Marina, et al.. (2003). P.2.041 High dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. European Neuropsychopharmacology. 13. S296–S297. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact